Frankincense (Ru Xiang) Pharmacology — The Anti-Inflammatory Resin Behind TCM Trauma Oils

If Dragon’s Blood (xue jie) is the crimson resin that closes a wound, frankincense — known in Traditional Chinese Medicine as Ru Xiang (乳香) — is the pale, amber tear that opens it back up. Open it, that is, in the TCM sense: opening blocked channels, dispersing stagnant Qi and Blood, and letting circulation return to swollen, bruised, or arthritic tissue.

Almost every classical Chinese trauma oil — the dit da jow your grandfather kept in a brown glass bottle, the Yunnan Baiyao precursor formulas, the Qi Li San powder — relies on the same resinous backbone: Ru Xiang paired with Mo Yao (myrrh), often joined by xue jie. They are inseparable in the literature for a reason. This article unpacks what frankincense actually does at the pharmacological level, why it is paired with myrrh rather than used alone, and what the modern science of boswellic acids tells us about a resin that has been burned, chewed, and rubbed onto bruises for at least three thousand years.

What Ru Xiang Actually Is

Frankincense is the dried oleo-gum-resin tapped from trees of the genus Boswellia, in the family Burseraceae. Workers slash the bark, the tree exudes a milky fluid, and over a few weeks the fluid hardens into translucent “tears” that range from pale lemon to deep amber. These tears are then graded, sorted, and either burned as incense, distilled into essential oil, or extracted into resinous tinctures and oils.

Several species are commercially relevant, and the species matters more than most herbalists let on:

When a Chinese pharmacopoeia or older medicated-oil label says “Ru Xiang,” it almost always means B. carterii. Modern industrial formulators may substitute B. serrata because of supply constraints and lower price, but the substitution is not pharmacologically silent — the boswellic acid profile and the volatile-oil composition shift, and the warming, opening character that classical TCM ascribes to carterii is at least partly a function of its specific terpene mix.

The Active Compounds: Two Chemistries in One Resin

Frankincense is unusual because the resin contains two pharmacologically distinct fractions, and a topical medicated oil generally captures both:

1. Boswellic acids (BAs). These are pentacyclic triterpenoid acids — heavy, non-volatile molecules that stay in the resin fraction rather than the steam-distilled oil. The clinically interesting ones are α-boswellic acid, β-boswellic acid, 11-keto-β-boswellic acid (KBA), and especially 3-O-acetyl-11-keto-β-boswellic acid (AKBA). AKBA is the heavyweight of the bunch and is the molecule most modern Boswellia supplements are standardized to.

2. Volatile terpenes. Steam distillation of the resin yields an essential oil dominated by monoterpenes — alpha-pinene, limonene, alpha-thujene (in serrata), incensole acetate, and a long tail of minor sesquiterpenes. These are the molecules you smell when frankincense is burned, and they are also the molecules that drive most of the acute topical effects: aroma-mediated relaxation, mild counter-irritation, and the warming sensation when applied to skin.

This split matters for medicated oils. A pure steam-distilled frankincense essential oil contains almost no boswellic acids. A traditional dit da jow soak, where ground resin is macerated in rice wine for weeks, captures both fractions because alcohol dissolves the boswellic acids that water and steam leave behind. A modern liniment that lists “frankincense oil” on the label may therefore deliver only the volatile fraction — useful, but not the same molecule as the one in the joint-health literature.

How It Works: The Pharmacology

Anti-inflammatory mechanism — the 5-LOX story

The signature pharmacology of boswellic acids is selective, non-redox inhibition of 5-lipoxygenase (5-LOX). 5-LOX is the enzyme that converts arachidonic acid into leukotrienes — pro-inflammatory signaling molecules implicated in asthma, inflammatory bowel disease, arthritis, and the swelling phase of acute soft-tissue injury.

Most NSAIDs (ibuprofen, naproxen, aspirin) work on the COX side of the same arachidonic acid cascade and leave the leukotriene branch untouched. AKBA hits the leukotriene branch directly, and does so without the redox-cycling that makes some other natural 5-LOX inhibitors irritating. In addition, boswellic acids inhibit COX-1 and -2 to a lesser degree and dampen NF-κB signaling — the master transcription factor for inflammatory cytokines like TNF-α and IL-6.

Translated into clinical terms: frankincense reduces the swelling and pain of inflammatory injuries through a mechanism that is complementary to NSAIDs rather than redundant. This is part of why traditional formulas pair Ru Xiang with mineral- or salicylate-bearing herbs — the targets do not overlap.

Analgesic and circulation-promoting effects

Both essential-oil fractions and resin extracts of B. sacra and B. carterii have demonstrated peripheral and central analgesic effects in animal models. The mechanism is not fully mapped but appears to involve a combination of the anti-inflammatory pathway above plus modulation of nociceptive signaling and improvement of local microcirculation.

In TCM language this is described as 活血止痛 (huo xue zhi tong) — invigorating blood, stopping pain. Modern microcirculation studies on Ru Xiang–Mo Yao pairs show measurable improvements in capillary perfusion and reductions in microvascular stasis at injury sites, which lines up neatly with the classical indication of using these resins for stagnant, unmoving pain — the kind of dull, deep ache that lingers after a sprain has technically healed.

Wound-healing and antimicrobial activity

Frankincense essential oil exhibits broad-spectrum antimicrobial activity in vitro, and resin extracts accelerate granulation tissue formation in animal wound models. For medicated-oil formulators this matters because liniments are routinely applied to scraped skin, broken blisters, or the small cuts that accompany contusions. A resin that simultaneously reduces inflammation, supports microcirculation, and inhibits superficial bacterial colonization has clear utility, even if the antimicrobial fraction is modest compared to a dedicated antiseptic.

The Ru Xiang–Mo Yao Pairing: Why They Travel Together

Open any classical Chinese trauma formula and you will almost never find frankincense alone. It travels with myrrh (Mo Yao, 没药) — the resin of Commiphora myrrha, also from the Burseraceae family, but a different chemistry entirely.

The pairing first appears formally in Lu Xiang Zhi Tong San (乳香止痛散, “Frankincense Pain-Stopping Powder”) in the Ming-dynasty Zheng Zhi Zhun Sheng, but informal pairings predate it by centuries. In TCM theory:

This is the Qi-and-Blood division that runs through all of TCM pharmacology. Frankincense addresses the flow dimension, myrrh addresses the substance dimension, and the two together cover both axes of stagnation. In a bruise, you have both a flow problem (channels blocked, Qi stuck) and a substance problem (extravasated blood pooling in tissue). One resin can address one axis; the pair addresses both, and the herbs are described as 相须为用 (xiang xu wei yong) — mutually necessary.

In a typical dit da jow, this pair is then completed by:

The classical Qi Li San formula — used for acute trauma since the Qing dynasty — is built around exactly this resinous core: frankincense, myrrh, dragon’s blood, and catechu, ground together into a strongly aromatic powder that can be taken internally or made into a topical paste.

Where You Will Find Ru Xiang in Modern Medicated Oils

Frankincense rarely appears as a headline ingredient on Asian medicated-oil packaging — it sits inside the herbal matrix. You are most likely to encounter it in:

Topical Safety and Sensitization

Frankincense has a mostly favorable safety profile, but it is not inert.

Contact dermatitis. Allergic contact dermatitis from B. carterii essential oil has been documented in the dermatological literature. The sensitizing components are not fully characterized but are likely a mix of oxidized monoterpenes (alpha-pinene oxidation products are well-known sensitizers) and minor resin components. Patch-test before first use on sensitive areas.

Concentration matters. Pure frankincense essential oil should not be applied undiluted to skin. Standard aromatherapy practice is 1–3% dilution for facial use and up to 5% for body application. Most commercial medicated oils sit at or below this concentration, and that is by design.

Tree-resin allergy. People with known reactions to other resinous botanicals — pine, balsam of Peru, propolis — are at elevated risk of cross-reaction with frankincense and should test cautiously.

Pregnancy. Boswellic acids are uterine stimulants in some animal models and frankincense has historically been used as an emmenagogue. Topical use during pregnancy is generally avoided, particularly over the abdomen and lower back. Inhaled frankincense (incense smoke or a diffuser at room concentration) is not the same exposure and is not the issue here.

Drug interactions (mostly oral). Oral boswellia extracts can theoretically interact with anticoagulants and with drugs metabolized by CYP3A4. Topical exposure delivers a small fraction of an oral dose, so interaction risk is low but not zero — patients on warfarin who use trauma oils heavily over large body areas should mention it to their physician.

G6PD deficiency. Unlike camphor and methyl salicylate, frankincense itself does not have a documented G6PD red flag. The other ingredients in the same medicated oil are usually the limiting factor.

How to Read a Medicated Oil Label for Frankincense

Three things to look for:

  1. Species. “Boswellia carterii” or simply “frankincense” in a Chinese-tradition formula is the expected species. B. serrata is the Indian/Ayurvedic substitute. B. frereana is essentially decorative — pleasant scent, very few boswellic acids.

  2. Form. “Resin extract” or “oleoresin” implies the boswellic acids are present. “Essential oil” alone implies only the volatile fraction. Traditional alcohol-extracted dit da jow captures both. Both forms are useful, but the indications differ — chronic joint inflammation benefits more from the resin fraction; acute aromatic counter-irritation from the volatile fraction.

  3. Companion herbs. A formula listing Ru Xiang without Mo Yao is unusual in the Chinese tradition and should make you wonder whether the formulator understood the pairing or was working from an abbreviated version. The two resins almost always belong together.

The Resin That Outlasts Empires

Frankincense has been traded along the Incense Route for over three thousand years. It was a gift fit for a king in the New Testament; a pharmacopeial staple in the Compendium of Materia Medica; an Ayurvedic anti-arthritic; and, today, a cornerstone of every serious Chinese trauma oil. The pharmacology has caught up only in the last two decades — boswellic acids and AKBA were not even isolated until the late twentieth century, and the 5-LOX mechanism was clarified more recently still.

What this means practically: the herb that the dit da master was rubbing into your shoulder in 1920 was working through a leukotriene-inhibition pathway that pharmaceutical researchers would not name until 1980. The traditional indication — stagnant pain, slow healing, dull bruise — maps cleanly onto a modern picture of low-grade chronic inflammation with poor microcirculation. That is a rare alignment in herbal medicine, and it is worth taking seriously the next time you smell that warm, peppery, faintly honeyed note in the bottom of a bottle of Chinese trauma oil.

It is the smell of three thousand years of bruises being persuaded to heal.

Further reading on this site:

Sources consulted: